Adjuvant therapy: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
9
Conditions studied
15
US states with sites
4
Countries
Phase breakdown
Phase 2 1
Phase 3 1
Conditions being studied
| Condition | Trials |
|---|---|
| Anlotinib | 1 |
| Lung cancer | 1 |
| Melanoma | 1 |
| Melanoma Stage IIIB | 1 |
| Melanoma Stage IIIC | 1 |
| Melanoma Stage IIID | 1 |
| NSCLC | 1 |
| Nab-paclitaxel | 1 |
| Tislelizumab | 1 |
Recruiting trials involving Adjuvant therapy
- Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- Tislelizumab Combined With Anlotinib and Nab-paclitaxel in III Resectable Non-small Cell Lung Cancer : A Prospective, Single-Arm, Phase II Study
Common questions
How many recruiting trials involve Adjuvant therapy?
2 recruiting trials across 9 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.